5 Oversold NASDAQ Stocks To Buy Right Now

2. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Number of Hedge Fund Holders: 33

14-day RSI as of March 13: 27.4

Citigroup analysts maintained a Buy rating and a $30.19 price target on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on March 12.

There were 33 hedge funds long ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) in the fourth quarter, with a total stake value of $1.9 billion.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a biotech company. It develops innovative medicines for central nervous system disorders and rare diseases.

Follow Acadia Pharmaceuticals Inc (NASDAQ:ACAD)